# FDA Inspection 969931 - Vitalant - April 01, 2016

Source: https://www.keypedia.com/records/fda_inspections/vitalant/775ecbee-46e2-4b58-b265-a798890a58de
Source feed: FDA_Inspections

> FDA Inspection 969931 for Vitalant on April 01, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 969931
- Company Name: Vitalant
- Inspection Date: 2016-04-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1250030 - 2024-09-19](https://www.keypedia.com/records/fda_inspections/vitalant/c5188362-6bb0-4c4a-a97c-378946b79c0c)
- [FDA Inspection 1250030 - 2024-09-19](https://www.keypedia.com/records/fda_inspections/vitalant/5595f92d-70d8-4c9d-874c-4764151588e6)
- [FDA Inspection 1100668 - 2019-07-29](https://www.keypedia.com/records/fda_inspections/vitalant/01f861c3-8b54-47cb-8cb5-c32d6f34537c)
- [FDA Inspection 859388 - 2013-12-18](https://www.keypedia.com/records/fda_inspections/vitalant/d93127ab-0415-4718-8605-21d3c070ba95)
- [FDA Inspection 753659 - 2011-11-15](https://www.keypedia.com/records/fda_inspections/vitalant/1602ec73-3285-4452-ae5b-0f0a1db13510)

Company: https://www.keypedia.com/companies/vitalant/63eb1275-a5bc-45eb-99be-de838f5482a2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d